1. Prognostic value of NOB1 expression levels in various cancers: a systematic review and meta-analysis
   Yi Zhang et al, 2024, Biomarkers in Medicine CrossRef
2. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1
   Yongtao Zhang et al, 2020, World Journal of Surgical Oncology CrossRef
3. RETRACTED ARTICLE: Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway
   Jun Dai et al, 2019, Journal of Translational Medicine CrossRef
4. NOB1: A Potential Biomarker or Target in Cancer
   Weiwei Ke et al, 2019, Current Drug Targets CrossRef
5. miR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein
   JIANTAO SUN et al, 2016, International Journal of Molecular Medicine CrossRef
6. Domain definition and preliminary functional exploration of the endonuclease NOBP-1 in Strongyloides stercoralis
   Huan Zhou et al, 2023, Parasites & Vectors CrossRef
7. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway
   Aling Shen et al, 2019, Cancer Research CrossRef
8. Non-coding RNAs related to angiogenesis in gynecological cancer
   Neda Rahimian et al, 2021, Gynecologic Oncology CrossRef
9. Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu)
   Xin Gao et al, 2022, Bioengineered CrossRef
10. Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review
    Zhaoyi Chen et al, 2017, Biomedicine Hub CrossRef
11. Establishment of a Novel Monoclonal Antibody L6 Specific to NOB1
    Yubo Ma et al, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy CrossRef